FDA Grants Approval for Sodium Bicarbonate ANDA220788 by ASPIRO
The FDA has granted approval for ANDA220788, a sodium bicarbonate formulation submitted by ASPIRO.
Asset / Drug
Drug and asset intelligence for ASPIRO with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.